These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11898135)
1. Patient age and cancer treatment decisions. Patient and physician views. Kutner JS; Vu KO; Prindiville SA; Byers TE Cancer Pract; 2000; 8(3):114-9. PubMed ID: 11898135 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570 [TBL] [Abstract][Full Text] [Related]
3. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531 [TBL] [Abstract][Full Text] [Related]
4. Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists. van Erning FN; Janssen-Heijnen ML; Creemers GJ; Pruijt HF; Maas HA; Lemmens VE J Geriatr Oncol; 2015 May; 6(3):219-24. PubMed ID: 25703856 [TBL] [Abstract][Full Text] [Related]
5. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance. Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878 [TBL] [Abstract][Full Text] [Related]
6. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea. Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187 [TBL] [Abstract][Full Text] [Related]
7. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients. Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804 [TBL] [Abstract][Full Text] [Related]
8. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619 [TBL] [Abstract][Full Text] [Related]
9. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Luo R; Giordano SH; Freeman JL; Zhang D; Goodwin JS Oncologist; 2006 Oct; 11(9):1025-33. PubMed ID: 17030645 [TBL] [Abstract][Full Text] [Related]
10. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer. van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW; Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338 [TBL] [Abstract][Full Text] [Related]
11. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. Ejaz A; Casadaban L; Maker AV J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636 [TBL] [Abstract][Full Text] [Related]
12. Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer. Moth EB; Vardy J; Blinman P Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1321-1340. PubMed ID: 27718755 [TBL] [Abstract][Full Text] [Related]
13. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717 [TBL] [Abstract][Full Text] [Related]
14. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Mahoney T; Kuo YH; Topilow A; Davis JM Arch Surg; 2000 Feb; 135(2):182-5. PubMed ID: 10668878 [TBL] [Abstract][Full Text] [Related]
15. Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. Wong AC; Stock S; Schrag D; Kahn KL; Salz T; Charlton ME; Rogers SO; Goodman KA; Keating NL J Oncol Pract; 2014 Sep; 10(5):e360-7. PubMed ID: 24986112 [TBL] [Abstract][Full Text] [Related]
16. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal. Gilbar P; Lee A; Pokharel K J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. Shankaran V; Jolly S; Blough D; Ramsey SD J Clin Oncol; 2012 May; 30(14):1608-14. PubMed ID: 22412136 [TBL] [Abstract][Full Text] [Related]
18. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists. Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117 [TBL] [Abstract][Full Text] [Related]
20. Patient factors associated with breast cancer screening among older women. Marwill SL; Freund KM; Barry PP J Am Geriatr Soc; 1996 Oct; 44(10):1210-4. PubMed ID: 8856000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]